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eart Rate-Corrected QT Interval Prolongation
redicts Risk of Coronary Heart Disease
n Black and White Middle-Aged Men and Women
he ARIC Study
acqueline M. Dekker, PHD,*† Richard S. Crow, MD,‡ Peter J. Hannan, MSTAT,‡
vert G. Schouten, MD, PHD,* Aaron R. Folsom, MD, MPH‡
ageningen and Amsterdam, the Netherlands; and Minneapolis, Minnesota
OBJECTIVES We aimed to study the predictive value of heart rate-corrected QT interval (QTc) for incident
coronary heart disease (CHD) and cardiovascular disease (CVD) mortality in the black and
white general population, and to validate various QT measurements.
BACKGROUND QTc prolongation is associated with higher risk of mortality in cardiac patients and in the
general population. Little is known about the association with incident CHD. No previous
studies included black populations.
METHODS We studied the predictive value of QTc prolongation in a prospective population study of
14,548 black and white men and women, age 45 to 64 year. QT was determined by the
NOVACODE program in the digital electrocardiogram recorded at baseline.
RESULTS In quintiles of QTc, cardiovascular risk profile deteriorated with longer QTc, and risk of
CHD and CVD mortality increased. The high risk in the upper quintile was mostly explained
by the 10% with the longest QTc. The age-, gender-, and race-adjusted hazard ratios for
CVD mortality and CHD in subjects with the longest 10% relative to the other 90% of the
gender-specific QTc distribution were 5.13 (95% confidence interval 3.80 to 6.94) and 2.14
(95% confidence interval 1.71 to 2.69), respectively. The increased risk was partly, but not
completely, attributable to other risk factors or the presence of chronic disease. The
association was stronger in black than in white subjects. Manual- and machine-coded QT
intervals were highly correlated, and the method of rate correction did not affect the observed
associations.
CONCLUSIONS Long QTc is associated with increased risk of CHD and CVD mortality in black and white
healthy men and women. (J Am Coll Cardiol 2004;43:565–71) © 2004 by the American
College of Cardiology FoundationQ
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the heart rate-corrected QT (QTc) interval in the resting
2-lead electrocardiogram (ECG) provides important prog-
ostic information in clinical practice. In post-myocardial
nfarction patients (1), subjects referred for Holter monitor-
ng (2), and subjects with diabetes (3) QTc prolongation is
See page 572
ssociated with mortality risk. In inheritable syndromes, which
re characterized by QTc prolongation, affected patients have
igh risk of sudden death (4). Also, in several population
tudies (5–10), increased risk of cardiovascular disease (CVD)
ortality was observed in subjects with QTc prolongation.
ess is known about the association with incident coronary
eart disease (CHD). Furthermore, though racial differences in
From the *Department of Epidemiology and Public Health, Wageningen Univer-
ity, Wageningen, The Netherlands, †Institute for Research in Extramural Medicine,
U University Medical Center, Amsterdam, The Netherlands; and the ‡Division of
pidemiology, School of Public Health, University of Minnesota, Minneapolis,
innesota. Supported by a grant from the Netherlands Organization for Scientific
esearch (NWO) (Dr. Dekker).
Manuscript received December 13, 2002; revised manuscript received August 15,6003, accepted September 17, 2003.T interval have been reported (11), there is no information
bout the association of QTc with CVD mortality or incident
HD in the black population. Therefore, we studied QT in
elation to risk of CHD incidence and CVD mortality in a
arge biracial U.S. population study, the Atherosclerosis Risk
n Communities (ARIC) study.
Because measurement of QT is hampered by systematic
ifferences between manual coders and between computerized
T measurements of different ECG systems (12), manually
etermined QT intervals were compared with machine-
erived QT intervals. In addition, to compare QT intervals
etween subjects, adjustment for differences in heart rate is
ssential. The widely used Bazett formula is known to over-
djust at very high and low heart rates, and several alternative
ethods have been proposed (13,14). We compared three
ommonly used formulae for the correction of heart rate.
ETHODS
tudy population. The ARIC study is following a cohort
f 15,792 middle-aged men and women (15). During 1987
o 1989, population samples were drawn from the 45- to
4-year-old inhabitants of Forsyth County, North Carolina;
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QT and CHD Risk in the General Population February 18, 2004:565–71ackson, Mississippi; the northwest suburbs of Minneapolis,
innesota; and Washington County, Maryland; they were
nvited for a home interview and a clinical examination. In
ackson, 46% of eligible subjects participated; approximately
5% participated in the other three centers. For the present
tudy, subjects with a self-reported history of physician-
iagnosed heart attack, prior cardiovascular surgery or
oronary angioplasty, or with 12-lead Minnesota Code
vidence of prior myocardial infarction were excluded,
eaving 14,672 subjects. After exclusion of subjects with
issing data on QT, the study population consists of 14,548
en and women.
aseline measurements. In the home interview, questions
ere asked about health behaviors, sociodemographics, and
isease history. The clinical examination included electro-
ardiography. After resting 5 to 10 min while electrodes
ere placed, a standard 12-lead ECG and a 2-min paper
ecording of a three-lead (leads V1, II, and V5) rhythm strip
ere made in the supine position. The QT interval from the
igital 12-lead ECG was determined by the NOVACODE
rogram (16). The NOVACODE program generates an
verage waveform derived from all 12 simultaneously mea-
ured leads. This allows the system to determine the QT
rom the earliest QRS onset to the latest offset of the
-wave. All NOVACODE measurements were visually
erified. When measurements between computer and oper-
tor differed by 5 ms, the operator’s reference points were
sed. Plasma total cholesterol and triglycerides were mea-
ured by enzymatic methods (17,18), and low-density li-
oprotein cholesterol was calculated using the Friedewald
ormula. High-density lipoprotein cholesterol was measured
fter dextran-magnesium precipitation of non–high-density
ipoproteins (19). Serum insulin was measured using a
adioimmunoassay (125I Insulin Kit, Cambridge Medical
iagnostics, Billerica, Massachusetts). Serum glucose was
ssessed by the hexokinase method. Prevalent diabetes
ellitus was defined as a fasting glucose level of 126 mg/dl
7.0 mmol/l) or more, nonfasting glucose level of 200 mg/dl
11.1 mmol/l) or more, and/or a history of, or treatment for,
iabetes. Three seated blood pressure measurements were
aken on the right arm, using a random-zero sphygmoma-
ometer. The mean of the last two measurements was used.
ypertension was defined as systolic blood pressure of 140
m Hg or more, diastolic pressure of 90 mm Hg or more,
r use of antihypertensive agents. The ratio of waist (um-
ilical level) and hip (maximum buttocks) circumferences
as calculated as a measure of fat distribution. Average
Abbreviations and Acronyms
ARIC  Atherosclerosis Risk In Communities study
CHD  coronary heart disease
CVD  cardiovascular disease
ECG  electrocardiogram
QTc  heart rate-corrected QT intervalarotid intima-media thickness was assessed using a stan- Hardized B-mode ultrasonic technique (20). Use of cardiac
edication was defined as self-reported use of medication
or angina pectoris, heart failure, or rhythm disturbances
uring the last two weeks.
ethods of follow-up. The method of follow-up has been
escribed previously (21). Briefly, interviewers contacted
articipants annually by telephone to identify hospitaliza-
ions and deaths. Death certificates and discharge lists from
ocal hospitals were surveyed by ARIC staff to detect
dditional deaths and cardiovascular events. For hospital-
zed patients with potential acute CHD events, trained
bstractors recorded the presenting signs and symptoms,
ncluding chest pain, cardiac enzymes, and related clinical
nformation. Up to three 12-lead ECGs were visually coded
sing the Minnesota Code, and wave-form evolution was
valuated using side-by-side comparisons. Out-of-hospital
eaths were investigated by means of the death certificate
nd, in most cases, an interview with next of kin and
uestionnaires completed by the patients’ physicians. Cor-
ner reports and autopsy reports, when available, were used
n validation. All potential in- and out-of-hospital clinical
HD events were reviewed and adjudicated by the ARIC
orbidity and Mortality Classification Committee using
ublished criteria (21).
In the present study, follow-up data through 1993 were
sed. Follow-up information on incident CHD and mor-
ality was complete for 95%. The CHD incidence was
efined as definite or probable myocardial infarction, cardiac
evascularization procedures (excluding thrombolytic ther-
py), or definite CHD death. Cardiovascular disease mor-
ality was based on the underlying cause from the death
ertificates: ICD-9 codes 390 to 459.
anual QT measurement. QT was manually determined
n a case-cohort sample from the ARIC study (21), consist-
ng of a random sample of 900 subjects, all incident CHD
ases, and all deaths. Measurements were performed at the
niversity of Minnesota ECG Coding Center, using a
igitizing tablet (Calcomp, Columbia, Maryland) and a
ersonal computer. Coders mounted the 3-lead two-min
hythm strip on the tablet, and used the mouse to mark QT
nset and T-wave offset and preceding RR intervals in three
onsecutive normal beats in all three leads. T-wave offset
as defined as the point of maximum change of slope as the
-wave merges with the baseline (6). This accords with the
ethod applied in the NOVACODE program (16). The
nter- and intracoder variability was evaluated by means of
nalysis of variance in a set of 10 ECGs, which were
easured three times by each coder. The QT interval was
sed as the dependent variable. Between-subject variance
as 356 ms2, the between-coder variance 79 ms2, and the
ntercoder variance 15 ms2.
ata analysis. The QT was corrected for heart rate using
hree different methods: Bazett (22) QTc  QT/
RR [QT and RR in s]), the linear method proposed byodges et al. (14) (QThodges  QT  1.75 [heart rate
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February 18, 2004:565–71 QT and CHD Risk in the General Population 60] [QT in ms]) , and by the method proposed by Rautaharju
13) (QTindex  QT · [heart rate  100]/656 [QT in ms]).
ge-, gender-, and race-adjusted baseline characteristics were
ompared over categories of gender-specific quintiles of QTc,
Thodges, and QTindex. Age-, race-, and gender-adjusted
aseline characteristics were derived from regression analyses,
sing the specific characteristic as the dependent, and age, gender,
nd QT categories as explanatory variables. Relative risk of
ardiovascular disease mortality, CHD incidence, and total mor-
ality in gender-specific quintiles and in the upper 10% of QTc, of
Thodges, and of QTindex were estimated using Cox propor-
ional hazards analysis in the complete cohort. In the multivariable
odels, we forced in risk factors, which were previously suggested,
s possibly confounding or mediating in the literature. For analyses
f the manually determined QT, Poisson regression for the
ase-cohort design was used (23).
ESULTS
he correlation between the three QTc values was high:
.81 between QTc and QThodges, 0.96 between QTc and
Tindex, and 0.96 between QThodges and QTindex.
ean QTc was 436 25 ms in black women, 435 23 ms
n white women, 421  27 ms in black men, and 422  22
s in white men. In Table 1, age-, gender-, and race-
djusted baseline characteristics are shown across gender-
pecific quintiles of QTc. In all groups, men and women,
nd in blacks and whites, a more adverse cardiovascular risk
rofile with increasing QTc was observed. Intima-media
hickness and the prevalence of hypertension, diabetes, and
able 1. Age-, Gender-, and Race-Adjusted Baseline Characteris
Characteristics* Q1 Q2
ge (yrs) 53.2 53.5
ace (% black) 30 23
ody mass index (kg/m2) 27.2 27.7
aist-to-hip ratio 0.914 0.921
eart rate (beats/min) 60 64
urrent smoking (%) 26 27
moking (cigarette yrs) 285 293
ystolic pressure (mm Hg) 120 121
ypertension (%) 26 28
riglycerides (mmol/l)‡ 1.13 1.17
otal cholesterol (mmol/l) 5.50 5.52
DL cholesterol (mmol/l) 1.36 1.36
nsulin (pmol/l)†‡ 60 64
lucose (mmol/l)† 5.46 5.48
iabetes (%) 10 12
ntima-media thickness (mm) 0.735 0.741
CG abnormalities (%)§ 21 21
ardiac medication (%) 4 3
otassium (mmol/l) 4.42 4.39
alcium (mg/dl) 9.82 9.80
uintile cut points for QTc were 403, 415, 425, and 440 ms for men and 417, 429, 4
ogistic regression for dichotomous variables, with quintiles as a continuous explanato
Because insulin and triglycerides were not normally distributed, the geometric mean
ny 4 or 5 codes (ST- and T-wave changes), or codes 7.1 to 7.6 (conduction disturb
ARIC  Atherosclerotic Risk in Communities study; ECG  electrocardiograplectrocardiographic abnormalities were greater with in- Qreasing QTc. Longer QTc was also associated with lower
erum potassium and calcium concentrations. Similar results
ere observed in categories of QThodges and QTindex
data not shown).
In Table 2, relative rates are shown in quintiles of QTc.
isk of CVD mortality, incident CHD, and total mortality
as greater with longer QTc in black men and women and
n white women. In white men, a U-shaped association was
bserved for CVD mortality. In the total cohort, the age-,
ender-, and race-adjusted hazard ratios of CVD mortality,
ut not of incident CHD, in the lowest quintile were higher
han in the second quintile. From the fourth quintile on,
elative risk for all end points increased. When adjusting for
ther cardiovascular risk factors one by one, none of these
xplained a large part of the increased risk. After adjustment
or all other risk factors combined, only risk in the highest
uintile was still significantly elevated. The large increase in
isk in the highest quintile was mostly explained by the 10%
ith the longest QT interval. The age-, gender-, and
ace-adjusted hazard ratios for CVD mortality and CHD
ncidence were about 4 and 2, decreasing to about 2 and 1.5
fter adjustment for all other risk factors (Table 3). Results
ere similar for QTc, QThodges, and QTindex. Stratifica-
ion for race showed higher relative risks among the black
han among the white population (Table 3). A test of
tatistical significance showed significant interaction be-
ween QT prolongation and race. Using race- and gender-
pecific cutoff points did not change the observed difference
data not shown). The reduction of the prognostic value of
n Gender-Specific Quintiles of QTc: The ARIC Study
QTc Quintiles
Q3 Q4 Q5 p for Trend*
53.9 54.0 54.9 0.0001
25 25 30 0.42
28.2 28.6 29.3 0.0001
0.925 0.934 0.944 0.0001
67 69 73 0.0001
26 27 31 0.0004
303 297 336 0.0001
122 125 129 0.0001
30 36 46 0.0001
1.20 1.26 1.35 0.0001
5.53 5.54 5.61 0.0001
1.37 1.34 1.31 0.0001
68 70 75 0.0001
5.49 5.50 5.55 0.0001
12 14 20 0.0001
0.745 0.748 0.767 0.0001
22 25 41 0.0001
3 4 6 0.003
4.37 4.34 4.26 0.0001
9.79 9.79 9.78 0.0001
d 454 ms for women. *Test for trend: linear regression for continuous variables, and
able; †Subjects with diabetes or not in fasting state were excluded for these analyses;
ented; §ECG abnormalities: presence of Minnesota codes 1.1, 1.2 (major Q waves),
).
DL  high-density lipoprotein; QTc  heart rate-corrected QT interval.tics i
40, an
ry vari
is pres
ances
hic; HTc prolongation in the multivariable model in the white
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QT and CHD Risk in the General Population February 18, 2004:565–71opulation was observed in the women only. This may be
ue to low event rates because none of the individual
ariables explained this. The effect was observed only when
ll variables were included, and it disappeared when a lower
utoff point was used.
The results did not differ over strata of heart rate,
iabetes, hypertension, or presence of ECG abnormalities.
hen stratifying for the presence of diabetes, hypertension,
se of cardiac medication, or ECG abnormalities combined,
he predictive value (after adjustment for other risk factors)
f QTc and QTindex was somewhat higher in the healthy
ubpopulation (Table 4).
The average machine-determined QT interval was 10 ms
onger than the manually determined QT, and the correla-
ion was 0.81. In the age- gender-, and coder-adjusted
able 2. Relative Rates (95% CI) of CVD Mortality, Incident C
ate-Adjusted QT
Quintile (n) CVD D
ge-adjusted
Black women n  44 (4, 4,
QTc Q1 (540) 1
Q2 (417) 1.30 (0.33–
Q3 (435) 0.30 (0.03–
Q4 (508) 2.57 (0.81–
Q5 (553) 5.79 (2.01–
White women n  27 (1, 2,
QTc Q1 (1,123) 1
Q2 (1,194) 1.86 (0.17–
Q3 (1,132) 4.75 (0.56–
Q4 (1,207) 7.90 (1.00–
Q5 (1,121) 8.29 (1.06–
Black men n  50 (1, 4,
QTc Q1 (355) 1
Q2 (254) 5.82 (0.65–
Q3 (256) 5.02 (0.56–
Q4 (296) 12.27 (1.58–
Q5 (317) 31.47 (4.28–
White men n  57 (14, 5
QTc Q1 (882) 1
Q2 (1,001) 0.29 (0.11–
Q3 (900) 0.39 (0.15–
Q4 (1,161) 0.53 (0.23–
Q5 (886) 1.22 (0.62–
otal cohort
Age-, gender-, and race-adjusted
QTc Q1 1
Q2 0.83 (0.43–
Q3 0.86 (0.45–
Q4 1.85 (1.08–
Q5 3.91 (2.40–
Adjusted for cardiovascular risk
factors†
QTc Q1 1
Q2 0.93 (0.43–
Q3 1.02 (0.49–
Q4 1.50 (0.79–
Q5 2.00 (1.07–
uintile cut points for QTc were 403, 415, 425, and 440 ms for men and 417, 429,
or age, gender, race, heart rate, hypertension, systolic blood pressure, ECG abnorma
DL cholesterol, triglycerides, use of cardiac medication, intima-media thickness, a
CHD  coronary heart disease; CI  confidence interval; CVD  cardiovasculaodel, the predictive value of the manual QTc was some-hat lower than that of the machine QT. However, this was
ue to the higher correlation of the machine QT with heart
ate; the Pearson correlations of manual- and machine-
oded QTc with heart rate were 0.33 and 0.48, respectively.
fter adjustment for heart rate, they had similar prognostic
alue (Table 5).
ISCUSSION
n this population-based cohort study of middle-aged men
nd women, a longer QTc was associated with an adverse
ardiovascular risk profile. Prolonged QTc was a strong
redictor of incident CHD and especially of CVD mortal-
ty, independent of the other risk factors. The association
as stronger in black than in white subjects.
and Total Mortality in Gender-Specific Quintiles of the Heart
CHD Incidence Total Mortality
, 25)* n  44 (6, 8, 3, 9, 18) n  104 (14, 13, 10, 23, 44)
1 1
1.73 (0.60–4.88) 1.21 (0.57–2.57)
0.61 (0.15–2.42) 0.66 (0.38–1.94)
1.52 (0.54–4.27) 1.69 (0.87–3.29)
) 2.75 (1.09–6.94) 2.93 (1.61–5.35)
10) n  85 (6, 12, 14, 19, 34) n  120 (20, 16, 19, 33, 32)
1 1
) 1.86 (0.70–4.96) 0.74 (0.39–1.43)
) 2.22 (0.85–5.77) 0.90 (0.48–1.69)
) 2.71 (1.08–6.79) 1.44 (0.82–2.50)
) 4.66 (1.95–11.15) 1.32 (0.75–2.31)
, 30) n  64 (6, 7, 11, 12, 28) n  117 (12, 13, 12, 28, 52)
1 1
) 1.70 (0.57–5.06) 1.58 (0.72–3.47)
) 2.30 (0.85–6.23) 1.21 (0.54–2.70)
) 2.20 (0.83–5.88) 2.53 (1.29–4.99)
4.96 (2.05–12.03) 4.35 (2.31–8.16)
1, 21) n  252 (38, 53, 40, 54, 67) n  173 (25, 29, 28, 33, 58)
1 1
1.18 (0.78–1.79) 0.94 (0.55–1.60)
0.98 (0.63–1.53) 0.99 (0.17–1.69)
0.99 (0.65–1.50) 0.85 (0.51–1.43)
1.54 (1.03–2.30) 1.76 (1.10–2.83)
1 1
1.39 (0.99–1.96) 1.06 (0.76–1.47)
1.22 (0.86–1.74) 1.01 (0.72–1.40)
1.36 (0.97–1.89) 1.42 (1.06–1.91)
2.34 (1.72–3.19) 2.28 (1.73–3.00)
1 1
1.31 (0.92–1.88) 1.04 (0.73–1.49)
1.16 (0.79–1.70) 0.98 (0.68–1.41)
1.20 (0.84–1.72) 1.10 (0.79–1.55)
1.55 (1.08–2.23) 1.33 (0.95–1.87)
nd 454 ms for women. *Number of cases (number of cases in Q1 to Q5); †Adjusted
body mass index, waist-hip ratio, current smoking, cigarette years, total cholesterol,
betes.
se; HDL  high-density lipoprotein; QTc  heart rate-corrected QT interval.HD,
eath
1, 10
5.20)
2.69)
8.18)
16.64
5, 9,
20.45
40.64
62.36
64.95
4, 11
52.08
44.93
95.15
231)
, 6, 1
0.82)
1.01)
1.16)
2.20)
1.63)
1.66)
3.15)
6.37)
1.97)
2.13)
2.87)
3.75)
440, a
lities,
nd diaQT was determined in the digital ECG, and manually in
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February 18, 2004:565–71 QT and CHD Risk in the General Populationhe three-lead rhythm strip, which were recorded at the
ame visit. We observed a high agreement between
achine- and manual-determined QT intervals, and both
ad similar prognostic value. Therefore, it can be concluded
hat NOVACODE-determined QT intervals can safely be
sed in population studies. This may not be true for patient
opulations, because the normal pattern is easier for auto-
atic measurements to detect (14).
able 3. Relative Rates (95% CI) of CVD Mortality, Incident C
ompared with the Other 90% of the QT Distribution*
CVD Death
ll Age-, g
Tc 5.13 (3.80–6.94)
Thodges 3.15 (2.29–4.35)
Tindex 3.57 (2.63–4.85)
Adjusted f
Tc 2.53 (1.74–3.69)
Thodges 2.45 (1.68–3.57)
Tindex 2.13 (1.48–3.06)
lacks n  3,931 Ag
umber of events/number at risk:‡ 46/3,451, 48/480
Tc 7.21 (4.80–10.82)
Thodges 4.06 (2.68–6.15)
Tindex 4.33 (2.87–6.53)
Adjusted f
Tc 3.14 (1.93–5.12)
Thodges 4.14 (2.49–6.90)
Tindex 3.95 (2.35–6.66)
hites n  10,617 Ag
umber of events/number at risk:‡ 59/9,601, 25/1,016
Tc 3.39 (2.12–5.44)
Thodges 2.22 (1.31–3.74)
Tindex 2.82 (1.76–4.53)
Adjusted f
Tc 1.72 (0.94–3.16)
Thodges 1.35 (0.71–2.54)
Tindex 1.55 (0.88–2.74)
Cut point for prolongation; QTc: 450 ms for men, 465 ms for women; QThodges: 44
or age, gender, (race in the combined analyses), heart rate, hypertension, systolic blood
ears, total cholesterol, high-density lipoprotein cholesterol, triglycerides, use of cardi
he lowest 90%, the upper 10%, respectively.
CHD  coronary heart disease; CI  confidence interval; CVD  cardiovascula
able 4. Relative Rates (95% CI) of CVD Mortality, Incident C
ompared with the Other 90% of the QT Distribution*, Accordi
CVD Dea
djusted for cardiovascular risk factors†
ubjects with any diabetes, hypertension, ECG abnormalities,‡ or using c
umber of events/number at risk 120/5,963
Tc 2.78 (1.88–4.
Thodges 2.91 (1.99–4.
Tindex 2.45 (1.68–3.
ubjects without diabetes, hypertension, ECG abnormalities, and not usin
umber of events/number at risk 26/7,140
Tc 6.38 (2.53–16
Thodges 3.72 (2.53–10
Tindex 4.39 (1.81–10
Cut point for prolongation: QTc: 450 ms for men, 465 ms for women; QThodges: 44
or age, gender, race, heart rate, systolic blood pressure, body mass index, waist-hip ra
riglycerides, and intima-media thickness; ‡ECG abnormalities: presence of Minneso
.1 to 7.6 (conduction disturbances).CHD  coronary heart disease; CI  confidence interval; CVD  cardiovascular diseaThe QT interval has to be corrected for heart rate to
ompare individuals with different heart rates. There are
everal methods, Bazett’s being the most commonly used.
s illustrated by our data, most methods will be highly
orrelated in a normal population. The Bazett correction
as been criticized for the residual correlation with heart
ate. However, this does not explain the association with
VD risk. In the present study adding heart rate to the age-
and Total Mortality in the Highest Gender-Specific 10%
CHD Incidence Total Mortality
r-, and, race-adjusted
2.14 (1.71–2.69) 2.35 (1.92–2.87)
1.76 (1.38–2.24) 1.81 (1.46–2.25)
2.03 (1.63–2.53) 2.06 (1.68–2.52)
rdiovascular risk factors†
1.51 (1.15–1.98) 1.37 (1.07–1.76)
1.36 (1.03–1.80) 1.59 (1.24–2.04)
1.47 (1.15–1.89) 1.43 (1.14–1.81)
gender-adjusted
72/3,451, 36/480 150/3,451, 71/480
3.47 (2.32–5.18) 3.23 (2.43–4.28)
3.33 (2.23–4.96) 2.41 (1.80–3.24)
3.42 (2.31–5.05) 2.46 (1.85–3.28)
rdiovascular risk factors†
2.07 (1.24–3.46) 1.77 (1.23–2.55)
2.55 (1.55–4.20) 2.20 (1.54–3.14)
2.08 (1.30–3.34) 1.66 (1.18–2.33)
gender-adjusted
278/9,601, 59/1,016 239/9,601, 54/1,016
1.76 (1.33–2.16) 1.73 (1.28–2.33)
1.29 (0.94–1.76) 1.35 (0.97–1.86)
1.64 (1.25–2.16) 1.74 (1.31–2.31)
rdiovascular risk factors†
1.39 (1.00–1.92) 1.12 (0.79–1.60)
1.08 (0.77–1.54) 1.17 (0.81–1.69)
1.35 (1.01–1.82) 1.30 (0.94–1.80)
r men, 451 ms for women; QTindex: 108 ms for men, 112 ms for women; †Adjusted
ure, ECG abnormalities, body mass index, waist-hip ratio, current smoking, cigarette
ication, intima-media thickness, and diabetes; ‡Number of events/number at risk in
h; QTc  heart rate-corrected QT interval.
and Total Mortality in the Highest Gender-Specific 10%
Health Status
CHD Incidence Total Mortality
medication
255/5,963 284/5,963
1.36 (1.01–1.83) 1.48 (1.13–1.95)
1.55 (1.16–2.08) 1.75 (1.34–2.28)
1.46 (1.06–1.85) 1.53 (1.18–1.98)
diac medication
138/7,140 155/7,140
2.40 (1.41–4.09) 1.71 (1.03–2.85)
0.93 (0.47–1.87) 1.54 (0.88–2.70)
1.97 (1.22–3.18) 1.86 (1.17–2.95)
r men, 451 ms for women; QTindex: 108 ms for men, 112 ms for women; †Adjusted
rrent smoking, cigarette years, total cholesterol, high-density lipoprotein cholesterol,
es 1.1, 1.2 (major Q waves), any 4 or 5 codes (ST- and T-wave changes), or codesHD,
ende
or ca
e- and
or ca
e- and
or ca
1 ms fo
press
ac medHD,
ng to
th
ardiac
26)
26)
56)
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.61)
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ortality for QTc, QTindex, and QThodges were 4.37,
.29, and 3.73, respectively. The prognostic value of QTc
as slightly better than QTindex or QThodges.
Certain drugs are known to lead to QTc prolongation,
nd may introduce bias. However, exclusion of subjects
sing antihypertensive or cardioactive drugs did not change
he observed associations in our study, and the associations
ere also present in subjects without signs of heart disease
r chronic diseases.
This study is in line with previous reports on the
ssociation of prolonged QTc with mortality risk (5–10) and
f CHD incidence (6,8). The finding of a gradually increas-
ng risk of CVD mortality with increasing QTc, and a
onlinear increase in the upper 10% of the population
istribution was also observed in the Strong Heart study of
merican Indians (10). We showed the QT-associated risk
ay be even higher in the black population. This may be a
eal phenomenon because there are known racial differences
n the 12-lead ECG, and race-specific criteria for left
entricular hypertrophy have been proposed (11,24). In
ealthy subjects without hypertension, diabetes, or his-
ory of cardiovascular disease in the ARIC study, black
ubjects had higher QRS voltage than white subjects, and
Tc was shorter, especially after adjusting for other
ardiovascular risk factors (11). When we increased the
ut point for prolongation for the white subjects in the
resent study, the relative risks in white subjects in-
reased somewhat, but they were still considerably lower
han in black subjects. Furthermore, racial differences
ave also been reported in the mechanism of CHD
eading to mortality (25). The observed higher risk may
ontribute to the higher case fatality in the black popu-
ation (26). The interaction with race may also be a
hance finding because previous studies reported higher
elative risks in white subjects with prolonged QTc than
bserved in the ARIC white population.
The QT interval reflects the time between the initial fast
epolarization of the ventricle and its repolarization. Several
Table 5. Comparison of Prognostic Value of M
Cohort Sample: Relative Rates (95% CI) of H
Other 90% of the QTc Distribution
Number of Events
CVD Death
n  178
Age-, gender- and coder-adjusted
QTc NOVACODE 4.89 (3.26–7.35)
QTc Manual 3.79 (2.44–5.88)
Age-, coder-, gender-, and heart rate-adjusted
QTc NOVACODE 2.24 (1.61–3.10)
QTc Manual 2.54 (1.87–3.45)
*Cut points for prolongation in the sample of 900 subjects:
manual: 446 ms for men and 455 ms for women.
CHD  coronary heart disease; CI  confidence interva
interval.echanisms have been reported to lead to QT prolongation:utonomic system imbalance and autonomic neuropathy
27), mutations of genes affecting cardiac ion channels
nvolved in cardiac repolarization (28), nonconducting scar
issue resulting from myocardial infarction (1), high glucose
evel (29,30), elevated insulin level (30–32), hypokalemia
32), obesity (33), and ventricular hypertrophy (16). All these
echanisms seemed to contribute to QT prolongation in the
RIC population. The QTc prolongation was associated
ith the presence of ECG abnormalities, possibly resulting
rom small silent myocardial infarctions; QTc duration was
lso strongly related to all cardiovascular risk factors, includ-
ng fasting insulin. This has previously been observed in
utch elderly men (6) and in the nondiabetic subjects of the
nsulin Resistance and Atherosclerosis Study (IRAS) (31).
he presence of all these factors of the insulin resistance
yndrome is expected to lead to atherosclerosis, and, indeed,
e confirmed the association between intima-media thick-
ess and QTc, also reported in IRAS. Thus, the QTc may
e viewed as a marker of subclinical atherosclerosis, which
ndeed may contribute to the increased incidence of symp-
omatic coronary heart disease associated with QTc prolon-
ation. However, the simultaneous presence of other car-
iovascular risk factors, ECG abnormalities, and intima-
edia thickness did not completely explain the association
etween QTc prolongation and either CHD incidence or
VD mortality. Gastadelli et al. (32) recently reported a
irect effect of exogenous insulin on QTc, which was
ediated through lowering of serum potassium and an
ncrease of noradrenaline levels. It was suggested that
nsulin-stimulated cellular potassium uptake leads to
yperpolarization of the cell membrane. In the present
tudy, adjustment for fasting insulin or potassium level
lso did not explain the increased risk of QTc prolonga-
ion. But this may be only one of several possible
echanisms of (acquired) suboptimal regulation of car-
iac ion channels involved in ventricular repolarization.
n analogy with the findings in subjects with the long QT
yndrome (28), this may directly be related to suscepti-
ility to both fatal and nonfatal arrhythmias.
al and Machine Measured QT in the Case
t Gender-Specific 10% Compared With the
CHD
Incidence
n  445
Total Mortality
n  514
1.95 (1.36–2.79) 2.17 (1.56–3.01)
1.62 (1.12–2.36) 1.81 (1.28–2.55)
1.48 (1.19–1.84) 1.49 (1.22–1.82)
1.45 (1.18–1.78) 1.52 (1.26–1.85)
NOVACODE: 454 ms for men, 464 ms for women; QTc
D  cardiovascular death; QTc  heart rate-corrected QTanu
ighes
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l; CVSome experimental work suggests subjects with QTc
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February 18, 2004:565–71 QT and CHD Risk in the General Populationrolongation may benefit from preventive treatment. In
bese subjects who lost weight, QT-interval duration nor-
alized (33). In addition, hypertensive rats treated with
ngiotensin-converting enzyme inhibitors showed a reduc-
ion of left ventricular mass and normalized QT (34).
In conclusion, apparently healthy men and women with
T prolongation are at increased risk of incident CHD, and
specially of CVD mortality. Therefore, QTc is a cheap and
oninvasive tool to detect high-risk subjects who should
eceive special attention.
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